Jiangxi Serum Pharma Industries Co., Ltd. stands as a beacon of reliability in the global biopharmaceutical landscape. Since our establishment in 2017, we have pioneered the export of critical biological products, vaccines, and Western medicines. Our presence in the London market is characterized by a deep understanding of the Golden Triangle (London-Oxford-Cambridge) life sciences ecosystem.
We don't just supply; we provide integrated solutions for cold-chain logistics, MHRA-aligned regulatory documentation, and strategic sourcing of high-purity APIs and biologicals. With a decade of dedicated expertise, we bridge the gap between advanced manufacturing in China and the rigorous demand for quality in the UK and European sectors.
Global Foundation
Global Partners
Verified Suppliers
Annual Sales
The London market serves as one of the world's most sophisticated hubs for clinical trials, pharmaceutical distribution, and medical innovation. With the expansion of districts like Paddington Life Sciences and the Knowledge Quarter, the demand for high-integrity vaccines and biologicals has reached an all-time high. Our services in the London area are designed to meet these specific industrial requirements, focusing on high-stability biologicals that can withstand the complexities of urban last-mile delivery.
We provide localized regulatory support, ensuring all products exported to the UK market align with MHRA (Medicines and Healthcare products Regulatory Agency) standards. Our documentation support covers GMP, BP, and USP certifications to ensure seamless market entry.
Enterprise procurement today demands more than just price; it requires resilience. We address global shortages of critical APIs and vaccines through a diversified supply chain that mitigates geopolitical risks and transport disruptions.
From large-scale immunization programs to specialized hospital supply chains, our solutions integrate data-driven forecasting to ensure that life-saving biologicals are available when and where they are needed most.
As we look toward 2030, the vaccine and biologicals sector is undergoing a paradigm shift. We are actively investing in three core technical routes to ensure our partners in the London market remain at the forefront of medical technology:
Customized nutrient and API blending for optimized manufacturing efficiency.
Enhancing stability and solubility of pharmaceutical ingredients.
Sustainable biological production of high-value compounds.
Natural plant-derived squalene and high-purity probiotics.
Exploring the shift toward sustainable sources in vaccine adjuvant production...
Read AnalysisWhy this API remains vital in modern emergency medicine and inflammation control...
Read MoreThe world's first oral GLP1 weight-loss drug marks a new era in metabolic therapy...
Read NewsAll our products are manufactured in facilities that meet international GMP standards. We provide documentation compliant with USP, BP, and EP (European Pharmacopoeia), ensuring suitability for the London and wider UK markets.
We utilize specialized pharmaceutical-grade freight services with temperature-controlled containers. Real-time GPS and thermal tracking data are provided for all vaccine and biological shipments to guarantee stability upon arrival.
Yes, we specialize in the customization of Pre-Mix, Co-Crystallization, and Bio-Fermentation services to meet specific clinical or nutritional requirements for our global enterprise partners.
While we are a supplier, we provide the full technical dossier (DMF, GMP certificates, etc.) required by UK-based entities to complete their MHRA filings successfully.
Partner with a trusted leader in vaccines and biologicals. Our London-market expertise ensures your procurement is efficient, compliant, and future-proof.
Send Inquiry Now
